Search Results for: THERAPEUTIC FOCUS Ischemic Stroke Treatment
Articles
THERAPEUTIC FOCUS - Ischemic Stroke: Treatment Beyond the First 3 Hours August 29, 2016
Rick Pauls, MBA, says treatment of ischemic strokes hinges on getting tPA into the patient within just few hours of the stroke occurring, but getting to the hospital quickly requires a great deal of luck, and anything that buys the patient more time is worth pursuing.
THERAPEUTIC FOCUS - Direct Effects(TM) Diabetic Neuropathy Therapy: Treating Symptoms & Modifying Disease June 2, 2015
Ronald Aung-Din, MD, reports that by using a unique methodology, symptomatic and neural restorative therapies treat DPN in preparations applied directly to areas of pathology, and therapeutic benefit is obtained in much shorter time than through blood flow.
BioTime Signs Agreements With Jade Therapeutics July 19, 2012
BioTime, Inc. recently announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a...Bayer Receives Fast Track Designation for Asundexian Atrial Fibrillation Program May 16, 2023
Bayer recently announced the US FDA has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential...PLATFORM TECHNOLOGY - Overcoming the Challenges of Drug Brain Delivery With a Novel Brain Delivery Vector November 23, 2020
Mei Mei Tian, PhD, explains how the xB3 platform has the potential to support development of treatments for CNS diseases that can treat thousands of patients in the years ahead.
SanBio Reaches Agreement on Manufacture of Regenerative Medicine Product With Hitachi Chemical March 20, 2018
SanBio Group and Hitachi Chemical Co., Ltd. jointly announced that, through an agreement with Hitachi Chemical Advanced Therapeutics Solutions, LCC,...ACS MARKET - Acute Coronary Syndrome Market 2015-2025 November 7, 2016
Michela J. McMullan, PhD, GlobalData Analyst, reports that although the ACS market is set to grow at a CAGR of 4.6%, reaching $12.1B by 2025, the potential for the market to be even more lucrative exists, especially in the sizable lipid-targeting arena.
7/25/2012 July 19, 2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was...
